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http://dxBackground: Pain control after thoracotomy prevents postsurgical complications and improves respiratory
function. The gold standard for post-thoracotomy analgesia is the epidural catheter. The aim of this study
was to compare it with a new technique that involves placement of a catheter in the paravertebral space at
the end of surgery under a surgeon’s direct vision.
Methods: FromNovember 2011 to June 2012, 52 patients were randomized into 2 groups depending on catheter
placement: an epidural catheter for group A and a paravertebral catheter for group B. At 12, 24, 48, and 72 hours
after surgery, the following parameters were recorded: (1) pain control using the patient’s completion of a visual
analog scale module, (2) respiratory function using forced expiratory volume in 1 second and ambient air satu-
ration, and (3) blood cortisol values as an index of systemic reaction to pain.
Results: Statistically significant differences (P<.05) were found in favor of group B for both cough and rest
pain control (P ¼ .002 and .002, respectively) and respiratory function in terms of forced expiratory volume
in 1 second and ambient air saturation levels (P ¼ .023 and .001, respectively). No statistically significant dif-
ferences were found in blood cortisol trends between the 2 groups (P>.05). Collateral effects such as vomiting,
nausea, low pressure, or urinary retention were observed only in group A. No collateral effects were recorded in
the paravertebral group.
Conclusions: According to our data, drugs administered through a paravertebral catheter are very effective.
Moreover, it does not present contraindications to its positioning or collateral effects. More studies are necessary
to confirm data we collected. (J Thorac Cardiovasc Surg 2014;147:469-74)Pain after standard thoracotomy is often present and associ-
ated with severe complications, such as atelectasis. This can
also develop into a severe pneumonia due to retention of se-
cretions.1-3 Pain prevents effective coughing, deep
breathing, and a patient’s mobility. Generally, strong pain
after surgery increases perioperative morbidity and may
also lead to chronic pain.4-6 At present, various
techniques are proposed and used to prevent thoracic pain
after thoracotomy. Among these, the most common is
thoracic epidural anesthesia (EA), considered to be the
gold standard.7-9
Our study compares the efficacy of EA with a tech-
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Mparavertebral space, resulting in paravertebral anesthesia
(PA).
This technique was previously proposed and tested
almost 20 years ago but never became very popular in clin-
ical practice.10,11 The most interesting and recent article on
this topic presents a systemic review and meta-analysis of
10 randomized trials by Davies and colleagues,12 including
520 adult patients. PA resulted the same in terms of pain
control, but was better as concerns contraindications and
adverse effects in comparison with EA. However, the
studies were of moderate quality because they did not use
uniform populations regarding positioning techniques,
drugs used, and largely because there were no blinding.
An EA catheter is usually placed by an anesthesiologist
immediately before surgery when the patient is awake, us-
ing local anesthesia to prevent positioning pain. This
method is contraindicated for patients taking anticoagulant
or antiplatelet drugs that cannot be suspended for the peri-
operative period or for those who have coagulopathies.13,14
Moreover, this technique may result in dangerous risks
during placement, including dural perforation, spinal cord
hematoma, spinal infection, or abscess.15,16 During
treatment some adverse effects may occur, including
hypotension, urinary retention, nausea, vomiting, or
itching.17-19 On the contrary, the PA catheter does notrdiovascular Surgery c Volume 147, Number 1 469
TABLE 1. Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Age>18 or<80 y Age<18 or>80 y
Karnofsky performance scale 70% Coagulopathies
American Society of Anesthesiology
Classification<IV
Therapies
Forced expiratory volume in 1 second
50% predicted
Allergies
Wegener’s granulomatosis (white blood cell
count>4000/mm3)
Spinal deformities
Primary systemic chemotherapy (platelet
count>100,000/mm3)
Neurologic diseases
Hemoglobin>8.5 g/dL Psychiatric diseases
Bilirubin<3.0 mg/dL Past thoracic surgery
Aspartate transaminase<2 times limits Pre-op thoracic drainage
Creatinine<3.0 mg/dL Past acute myocardial
infarction
Carbon dioxide tension<50 mm Hg Abuse of alcohol or drugs
Body mass index>30
Pregnancy
Pre-op, Preoperative.
Abbreviations and Acronyms
EA ¼ epidural anesthesia
FEV1 ¼ forced expiratory volume in 1 second
PA ¼ paravertebral anesthesia
VAS ¼ visual analog scale
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Mpresent any contraindications during placement and, due to
the drugs used and to the anatomical space where they are
administered, it has no side effects. Two different
approaches for placing the catheter in the paravertebral
space are used: a blind approach, also known as an
anesthetic approach, using the loss of resistance technique
first described by Eason andWyatt,17 and a de visu approach
where the catheter is placed by a surgeon at the end of the
thoracotomy.18
The aim of our study was to investigate if PA is as effec-
tive as EA in patients undergoing thoracotomy. Our primary
outcomewas to compare pain control, both at rest and while
coughing, between the 2 groups. Our secondary outcome
was to compare surgical stress and respiratory function in
these patients.
MATERIALS AND METHODS
The study was approved by the local ethics committee of St Paolo Hos-
pital at the University of Milan (No. 9898). All recruited patients provided
informed and written consent to the study. We considered patients who un-
derwent muscle-sparing thoracotomy for surgery due to pulmonary
neoplastic diseases, pleuric empyema, lung volume reduction surgery,
bronco-pleural fistula, or infectious diseases. Our inclusion and exclusion
criteria are reported in Table 1. The study was prospective, randomized,
and double-blind.
Patients were recruited between November 2011 and June 2012 and
randomly located by computer-generated randomization in 1 of the
following 2 groups: Group A, EA with infusion through the catheter of
0.001% fentanyl (10 mg/mL) with 0.1% bupivacaine. Group B, PA
with infusion of 0.3% naropine (5-10 mL vials 10 mg/mL in 100 cc
0.9% saline solution). Each patient in the 2 groups had simultaneous
infusion of paracetamol (1-500 mg vial) 4 times a day and the opportu-
nity to ask for tramadol (1-50 mg/1 mL vial in 100 cc of 0.9% saline if
visual analog scale (VAS) score was>6 maximum twice a day). Any
other requests by patients to be administered more pain medication
were recorded and satisfied.
All patients were pretreated with sublingual morphine. In group A the
epidural catheter was placed immediately before surgery according to
the standard techniques. The patient was awake and placed in a seated po-
sition and the interspace T5/6, T6/7 was detected; using the midline
approach and the loss of resistance technique, the catheter was inserted.
In group B the paravertebral catheter was placed at the end of surgery using
the de visu technique: an 18-gauge Thohy needle was placed through the
chest wall at an appropriate site in the same interspace as the thoracotomy
incision. The needle’s obturator was removed and the catheter passed
through and emerged inside the thoracic cavity. A localized extrapleural,
paravertebral pocket was then created by placing a gently curved clamp un-
der the parietal pleura at the posterior end or apex of the intercostal inci-
sion. Then, the catheter was gently prompted inside the pleural pocket
and pushed close to the paravertebral space. Once positioned, a piece of he-
mostatic sponge was placed at the entrance of the pleural pocket to avoid
spreading of medication. The external side of the catheter was then fixed470 The Journal of Thoracic and Cardiovascular Surgto the skin with a transparent patch. We always placed 2 chest tubes before
thoracotomy closure. All surgeries were performed by AB and FR. In each
group the catheter was removed on the same day that the final chest tube
was removed, between the third and fifth day after surgery, except for 1 pa-
tient with prolonged air leaks.
We arbitrarily identified the length of surgery as the period from the
arrival of patients in the operating room area to the end of thoracotomy
closure. To evaluate pain systemic response blood cortisol was measured
30 minutes after thoracotomy and then at 6, 12, 24, 48, and 72 hours after
surgery. Pain level was measured using a VAS, where 0¼ indicates no pain
and 10 ¼ severe pain, at 6, 12, 24, 48, and 72 hours after surgery. To eval-
uate pulmonary function at 6, 12, 24, 48, and 72 hours, forced expiratory
volume in 1 second (FEV1) and ambient air saturation were measured.
Possible drug-related complications such as urinary retention (defined as
Foley catheter replacement after initial removal), itching, nausea/vomiting,
or postural hypotension were recorded in the postoperative period. We
evaluated pain using the VAS scale, both at rest and while coughing, during
the 3 months postsurgical clinical control, and recorded the patients’ VAS
scale answers. All data were recorded by the research fellow (ie, AR). Nor-
mally distributed results were compared by Student t test analysis and non-
normally distributed results were compared by Mann-Whitney analysis.
The population of the recruited patients was calculated to be sufficient
for obtaining statistical significance.RESULTS
From November 2011 to June 2012, 52 patients were
enrolled and randomized for the study. Three patients
were excluded from the EA group due to an erroneous loca-
tion of the catheter and 1 patient was excluded from the PA
group because of accidental removal of the catheter. The 2
groups were composed of 24 patients each, 50% and 54%
men in the EA and PA groups, respectively. The mean pa-
tient age was 78 years in both groups. No statistical signif-
icance was found in the demographic traits (ie, weight,
height, and body mass index) of the 2 groups (P> .468)
(Table 2). No patients in either group had a prior historyery c January 2014
TABLE 2. Demographic traits of participants
Demographic characteristic Total (N ¼ 48) Group A (n ¼ 24) Group B (n ¼ 24)
Sex, men 25 (52.08) 12 (50.0) 13 (54.2)
Age, y 78.54  7.787 (80.00 [51-92]) 78.63  5.523 (80.00 [65-89]) 78.46  9.664 (80.5 [51-92])
Weight, kg 78.02  10.20 (72.00 [52-100]) 76.92  11.36 (74.50 [52-100]) 79.13  8.994 (79.50 [62-98])
Height, cm 168.96  5.149 (169.5 [158-180]) 168.75  5.007 (170.0 [159-180]) 169.17  5.387 (169.0 [158-180])
Body mass index 27.3518  3.517 (27.20 [18.21-33.9]) 27.050  4.067 (27.30 [18.21-33.91]) 27.653  2.924 (27.20 [21.71-32.79])
Values are presented as n (%) or mean  standard deviation (median [min-max]).
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Mof thoracic surgery and none had known allergies. All pa-
tients had surgeries for lung cancer, except for 1 who had
surgery for a lung abscess.
The length of surgery was 141.3 minutes for the EA
group and 108.6 minutes for the PA group with a statistical
significance in favor of the PA group (P<.0001) (Table 3).
There were no recorded adverse effects in the PA group, in
contrast with the EA group, in which we found 9 out of 24
(37.5%) patients with postural hypotension, 6 out of 24
(25%) patients with urinary retention, 6 out of 24 (25%)
with itching, and 8 out of 24 (33.3%) with nausea or vom-
iting (Table 3). No mortality was reported. The only surgi-
cal complication was 1 patient with prolonged air leaks. In
the 2 groups there was no difference in terms of hospital
length of stay.
FEV1 measurements were taken preoperatively and at 6,
12, 24, 48, and 72hours after the operationwith statistical sig-
nificance (P ¼ .023) in favor of the PA group. VAS was re-
corded at 6, 12, 24, 48, and 72 hours after operation both at
rest and while coughing with statistical significance in favor
of the PA group (P¼ .002). Ambient air saturation was taken
at 6, 12, 24, 48, and 72hours after the operationwith statistical
significance in favor of PA group (P ¼ .023). Cortisol blood
levels were measured at 30 minutes after the surgery and
then at 6, 12, 24, 48, and 72 hours after operation with no sta-
tistical significance (P ¼ .08) among the 2 groups (Table 4).
Data were then also exactly analyzed, comparing variables
at each moment of recording. VAS records, at rest and while
coughing, always presented statistical significance in favor of
the PA group at 6, 12, 24, 48, and 72 hours after the surgery.
Ambient air saturation and FEV1 presented a statistical sig-
nificance in favor of the PA group at 24, 48, and 72 hours after
the surgery. Cortisol level records did not have a statistically
significant variance at any time.
None of the patients in either groups required additional
pain medication.TABLE 3. Perioperative characteristics of participants
Characteristic Total (N ¼ 48) Grou
Length of surgery, min 124.9  19.61 (122.5 [95-154]) 141.3  10.
Allergy (no) 48 (100.0)
Hypotension (yes) 9 (18.75)
Urinary retention (yes) 6 (12.50)
Vomiting/nausea (yes) 8 (16.66)
Hitch (yes) 6 (12.50)
Data are presented as mean  stardard deviation (median [min-max]) or n (%). *P<.05.
The Journal of Thoracic and CaThree months after surgery there was no statistical differ-
ence in pain between the 2 groups.
DISCUSSION
Pain is themost important factor responsible for disorders
in a patient’s respiratory mechanism and pulmonary func-
tion in the perioperative period after thoracic surgery.1-6 It
has different origins, making its etiology very complex.
Pain impulses originating from stimuli from the chest wall
and parietal pleura pass along the intercostal nerves; in
addition, those originating from diaphragmatic pleura
ascend within the afferent fibers within the phrenic nerves,
and those from the lung and mediastinum are carried by
the vagus nerve. Surgical techniques influence the nature
and intensity of postoperative pain. Standard thoracotomy
is more painful than limited thoracotomy and video-
assisted thoracoscopic surgery.19 We adopted a muscle-
sparing incision that is a fairly conservative thoracotomy.20
In particular, in the case of thoracotomy, retraction on the
posterior spinal muscles determines stimuli transmitted by
the posterior primary branches of the spine and the incision
pain is mediated by the anterior branches. Moreover, sym-
pathetic nerves mediate pain from the visceral pleura,
lung, and neuro-humoral factors. All of these pathways
establish stimuli for the origin of pain and must be blocked
to dominate pain.
Following thoracic surgery, a restrictive respiratory
pathway develops, which decreases to approximately
40% the baseline values of FEV1, forced vital capacity,
and functional residual capacity. The relationship between
functional residual lung capacity and closing capacity pre-
dicts if atelectasis will develop; a decreasing functional re-
sidual lung capacity to a value less than closing capacity
leads to airway narrowing or closure, which produces an
area with a low ventilation perfusion relationship. Simulta-
neously, postoperative pain highly limits voluntary deepp A (n¼ 24) Group B (n ¼ 24) P
09 (146.0 [118-154]) 108.6  11.170 (108.0 [95-140]) <.0001*
24 (100.0) 24 (100.0) 1.00
9 (37.5) 0 (0) 0.002*
6 (25) 0 (0) 0.022*
8 (33.3) 0 (0) 0.004*
6 (25) 0 (0) 0.022*
rdiovascular Surgery c Volume 147, Number 1 471
TABLE 4. Overall results
Parameter 24 h 6 h 12 h 24 h 48 h 72 h P
Visual analog scale — 5.92  1.269 4.62  1.540 3.60  1.572 2.98  1.545 2.78  1.608 .002*
— 6.00 (2-8) 5.00 (1-7) 4.00 (1-7) 3.00 (1-7) 2.00 (1-7)
Vas cough — 6.10  1.276 4.79  1.641 3.62  1.556 3.09  1.607 2.87  1.687 .002*
— 6.00 (2-9) 5.00 (1-8) 4.00 (1-7) 3.00 (1-7) 2.00 (1-7)
Cortisol — 16.33  4.400 13.74  3.564 11.85  3.789 9.42  2.387 8.00  2.456 .08
— 18.00 (5-22) 14.00 (6-22) 11.00 (5-20) 9.90 (5-16) 8.00 (4-14)
Saturation 96.77  1.387 91.35  3.049 94.26  2.059 94.93  1.959 96.13  1.546 96.64 1.264 .001*
97.00 (93-99) 92.00 (81-96) 95.00 (89-98) 95.00 (90-98) 96.00 (93-99) 96.00 (95-99)
Forced expiratory volume
in 1 second
79.63  10.724 — 47.62  10.233 52.53  11.918 56.27  10.672 60.67  9.888 .023*
83.00 (51-95) — 45.00 (33-76) 50.00 (39-79) 57.00 (39-81) 61.00 (40-82)
Data are presented as mean  standard deviation or median (min-max). *P<.05.
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Mbreathing, coughing, and patient mobility, all necessary to
break down atelectasis. All of these conditions can be asso-
ciated with respiratory infection.20 Many modalities for the
management of post-thoracotomy pain are known. Intrave-
nous narcotic drugs may work adequately, but are related to
cough suppression, as well as central nervous system and
respiratory depression, leading once again to retention of
secretions and atelectasis. To limit the effects of systemic
narcotics, EA has been used extensively and is considered
to be the gold standard for pain relief after thoracic
surgery.7-9 This technique allows direct anesthetization of
the spinal branches and sympathetic nerves using less
narcotic drugs with excellent control of pain and
decreased respiratory and central nervous system
depression.5,6
EA presents several intrinsic contraindications that are
absolute (eg, coagulopathy, local sepsis, allergy to amide
local anesthetics, and anatomical anomalies) and relative
(activated partial thromboplastin time ratio or international
normalized ratio 1.2-1.4).21 Technical difficulties with
insertion have been reported in up to 11% of patients. Bilat-
eral effects of local anesthetic on the sympathetic chain
have been associated with increased rates of hypotension,
itching, vomiting/nausea, urinary retention, and sometimes
mental status changes and respiratory depression have been
observed.
PA technique presents several advantages in comparison
with EA. It does not have contraindications concerning coa-
gulopathies or anatomical anomalies and is free of any sys-
temic collateral effects because only local anesthetics are
used. The PA is placed at the end of surgery, whereas pa-
tients are still under anesthesia, through a safe and easy to
learn surgical technique.
Our results show that there has always been a significant
difference in favor of PA as far as pain management is con-
cerned, both at rest and while coughing, in the 72 hours after
surgery. Data also proves that PA is more effective than EA
concerning respiratory outcomes both for pulmonary func-
tion in terms of FEV1 (P¼ .023) and ambient air saturation
(P ¼ .023).472 The Journal of Thoracic and Cardiovascular SurgConcerning its placement, a PA catheter presents conve-
nient advantages. It is an intraoperative maneuver per-
formed by surgeons in 4 to 5 minutes, reducing the
patient’s stay in the operating room area. It should also be
emphasized that PA is suitable for patients in whom an
EA catheter was not placed because the procedure started
in video-assisted thoracoscopic surgery and then converted
to a thoracotomy. It is remarkable that our results demon-
strate the absence of adverse effects in the PA group sug-
gesting minor affects on this technique.
The strength of our study lies in the prospective random-
ization nature and the collection of objective data, such as
FEV1, blood cortisol level, and saturation and oxygen ten-
sion level. The most important limitations are represented
by the limited number of patients recruited, even though
sufficient to reach statistical significance, and the influence
of patients’ personal evaluation of pain.CONCLUSIONS
The PA catheter is safe and effective and should be al-
ways considered as an EA catheter alternative. In any
case, the PA and catheter placement technique should be
known by all thoracic surgeons.
This research won the Romeo and Enrica Invernizzi award. The
authors thank Dr Radaelli Giovanni for providing statistical assis-
tance in the preparation of this manuscript.References
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MDiscussion
Dr Arjun Pennathur (Pittsburgh, Pa). At the University of
Pittsburgh we published a randomized study of epidural versus
paravertebral catheters about 10 years ago. What we found was
equal pain control between the 2 groups, but the Foley catheter pa-
tients who had an epidural catheter needed it longer.
So my question is regarding the design of the study. Did you
standardize who placed the epidural catheter? Epidural catheter
placement is a technical thing and there are differences between
anesthesiologists who place it and its effectiveness. Do you
know how to standardize your epidural catheter arm? Is it done
by a group of anesthesiologists specializing in pain control, for
example?
And the second thing is for many of the pain-associated symp-
toms, it is also believed that the epidural catheter should be placed
before the incision similar to the paravertebral catheter beingThe Journal of Thoracic and Caplaced before the actual incision and the trauma of the surgery
when you measure the mediators and so forth.
I was wondering if you showed an intraoperative picture of
placing a paravertebral catheter, but in your randomization
scheme, did you consider placing the paravertebral catheter preop-
eratively, before actually making the skin incision?
Dr Federico Raveglia (Milan, Italy). The anesthesiologist who
performed the procedure was always the same, and the anesthesi-
ologists involved were all skilled in doing that procedure. So I
think that the position of the epidural catheter was always the
same.
Concerning the paravertebral catheter, it is always the same to
do that, so I think the 2 groups were pretty standardized.
Dr Harold M. Burkhart (Rochester, Minn). He also asked if
you considered putting the paravertebral catheter in before the
incision.
Dr Raveglia. The paravertebral catheter is placed before the
incision because it used to be placed with the patients awake to
start the treatment before the issue itself. It’s more effective.
The choice to place the paravertebral catheter after the incision
was made because we like to analyze just the surgical procedure.
Doing it during the operation we were focused to understand if
placement of the catheter by the surgeon could reduce the time
of the procedure itself.
Dr Christian R. Galvez-Padilla (Pittsfield, Mass). Thank you
very much for your talk. It was very nice. I am a single thoracic
surgeon at a small hospital, so I put in all the paravertebral cathe-
ters myself. So it is easy to know that the technique is always the
same. I have started to put in the catheters as the second step of the
procedure. I perform video-assisted thoracoscopic surgery for all
lobectomies; I put in a single 5-mm port for the camera and then
put the paravertebral catheter next, to have good pain control
from the start of the procedure.
The problem I’ve seen is that when the catheter is removed, the
pain starts, and patients require narcotics. For how long are you
leaving in the paravertebral catheter, and what is your experience
with pain control when the catheter comes out?
Dr Raveglia. Yes. In this study, we removed it 3 days after
surgery. Then we studied the analgesics, local anesthetic, and
preferential local anesthetic, and we did not have the impres-
sion that we need to leave the catheter in for more time after
the 3 days.
But this study was made of 20 patients for the group, as you see.
So maybe if there was a bigger group, we might find that we need
more time to leave the catheter inside the patient.
Dr Andrew C. Chang (Ann Arbor, Mich). Thanks for doing
this study. It is hard to complete a study such as yours. How
do you consent patients for this? Do you inform the patient
that he or she will receive either an epidural catheter before their
operation or a paraspinous catheter placed after the operation is
completed?
Because they already know what type of analgesia they’re get-
ting, when they report their pain as measured by the visual analog
scale, they already may be biased in terms of pain relief.
Regarding the methodology, how did you discuss this with the
patients?
My second question is regarding the small sample size, which
seemed quite small for the P values that you reported. Howrdiovascular Surgery c Volume 147, Number 1 473
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Mmuch of an effect were you expecting to find that you would
consider statistically significant? That is, when you decided to
study 50 patients, how much change in your outcomes, in your vi-
sual analog scale were you expecting to see that you would
consider significant? Because you had 25 patients in each arm,
so to be able to get enough..
Dr Raveglia.We asked for the statistics, specifically how many
patients would be necessary to do this kind of study. Our statisti-
cian said that this number of patients was sufficient to have statis-
tical data, so that is why we stopped with this number. But we are474 The Journal of Thoracic and Cardiovascular Surggoing on at the hospital, so maybe next year we will have a bigger
population.
Dr Chang. And were all patients getting the same operation or
were there different types of operations?
Dr Burkhart. Were they all the same operation or different
operations?
Dr Raveglia. The thoracotomies were always the same. We
decided to treat every patient with the thoracotomy independent
of kind of operation, no valve resection or lobectomy for cancer.
Thoracotomy was the inclusion criteria.ery c January 2014
